Home › Hyperlipoproteinemia Type II › Utah › Salt Lake City
Hyperlipoproteinemia Type II clinical trials in Salt Lake City, UT
3 studies for Hyperlipoproteinemia Type II are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
RecruitingPhase 3
- Primary Childrens Medical Center, Salt Lake City
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
RecruitingPhase 3
- Primary Childrens Medical Center, Salt Lake City
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
RecruitingPhase 3
- Primary Childrens Medical Center, Salt Lake City
- Primary Childrens Medical Center, Salt Lake City
Other studies in Salt Lake City
- Non-Small Cell Lung Cancer31 studies
- Cancer (all types)27 studies
- Breast Cancer27 studies
- Colorectal Cancer22 studies
- Lung Cancer21 studies
- Melanoma21 studies
- Multiple Myeloma21 studies
- Metastatic Cancer20 studies
- Ovarian Cancer19 studies
- Obesity18 studies
- Acute Myeloid Leukemia17 studies
- Heart Failure17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.